Top Story

African Americans in VA system demonstrate better multiple myeloma outcomes than Caucasians

May 21, 2019

City of Hope provost admitted into Association of American Physicians

May 20, 2019
Steven T. Rosen, MD, provost and chief scientific officer at City of Hope, has been admitted into the Association of American Physicians. The nonprofit association…
Meeting NewsPerspective

Lenalidomide delays progression to multiple myeloma

May 15, 2019
Early treatment with lenalidomide significantly reduced the risk for progression of high-risk smoldering multiple myeloma to symptomatic multiple myeloma, according to…
FDA News

P-BCMA-101 receives orphan drug designation for multiple myeloma

May 15, 2019
The FDA has granted orphan drug status to P-BCMA-101, a cell-based immunotherapy for the treatment of relapsed or refractory multiple myeloma. P-BCMA-101 (Poseida…
More Headlines »

Sickle Cell Disease Forum: Innovation in Drug Development and Emerging Science

This activity is supported by an educational grant from Global Blood Therapeutics.

Sickle cell disease (SCD) is an inherited molecular condition whose clinical severity has extreme phenotypic…
More »
Meeting News Coverage

VIDEO: Physicians must wait for STAMINA data to ‘really play out’ for posttransplant myeloma treatment

December 29, 2016
More »
Resource Centers
At Issue: Multiple Myeloma Resource Center

At Issue: Multiple Myeloma Resource Center


Ace the Case: A 67-Year-Old Man Presents With Pain and Swelling of His Hands and Knees

There is no commercial support for this activity.

This educational activity will utilize a case study to discuss the assessment and management of a 67-year-old man who…
More »